MBC BioLabs
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
39Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Sana Biotechnology | Biotech | Active | Jun 26, 2020 | $866.9M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Caribou Biosciences | Biotech | Public | Mar 5, 2021 | $132.4M |
| Achaogen | Biotech | Closed | May 16, 2017 | $89.7M |
Peer ranks
Portfolio size#108
Portfolio exits#103
Raises, 12 months#88
Co-investors#47
Co-investors
- Alexandria Venture InvestmentsVenture capital1 shared
- AmazonVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
- Astellas Venture ManagementVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Bay City CapitalVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.